Table 2 Primary and secondary outcomes, and assessment method
Primary/ secondary | Outcome variable | Assessment method |
|---|---|---|
Primary | Uptake of screening | laboratory database |
Secondary 1 | GDM prevalence | laboratory database |
Secondary 2 | Timing of screening | laboratory database |
Secondary 3 | Time to access antenatal diabetes care | Hospital database |
Secondary 4 | Pregnancy outcomes: | Hospital database |
Maternal outcomes | ||
Caesarean section delivery | ||
Assisted normal delivery | ||
Hypertension | ||
Pre-eclampsia texaemia (PET) | ||
Antepartum haemorrhage (APH) | ||
Post-partum haemorrhage (PPH) | ||
Neonatal outcomes: | ||
Miscarriage | ||
Foetal death intrauterine (FDIU) | ||
Stillbirth | ||
Admission to neonatal intensive care unit (NICU) | ||
Length of stay at NICU | ||
Gestational age | ||
Size for gestational age | ||
Congenital malformations | ||
Apgar scores | ||
Respiratory distress | ||
Hypoglycemia | ||
Jaundice | ||
Composite perinatal score (neonatal hypoglycemia, respiratory distress, need for phototherapy, birth trauma, 5-minute Apgar score less than 7, or prematurity). |